Navigation Links
Polar research reveals new evidence of global environmental change
Date:2/25/2009

c as well. Due to global warming, the types and extent of vegetation in the Arctic shifted, affecting grazing animals and hunting.

Other evidence for global warming comes from IPY research vessels that have confirmed above-global-average warming in the Southern Ocean. A freshening of the bottom water near Antarctica is consistent with increased ice melt from Antarctica and could affect ocean circulation. Global warming is thus affecting Antarctica in ways not previously identified.

IPY research has also identified large pools of carbon stored as methane in permafrost. Thawing permafrost threatens to destabilize the stored methane -a greenhouse gas- and send it into the atmosphere. Indeed, IPY researchers along the Siberian coast observed substantial emissions of methane from ocean sediments.

In the area of biodiversity, surveys of the Southern Ocean have uncovered a remarkably rich, colourful and complex range of life. Some species appear to be migrating poleward in response to global warming. Other IPY studies reveal interesting evolutionary trends such as many present-day deep-sea octopuses having originated from common ancestor species that still survive in the Southern Ocean.

IPY has also given atmospheric research new insight. Researchers have discovered that North Atlantic storms are major sources of heat and moisture for the polar regions. Understanding these mechanisms will improve forecasts of the path and intensity of storms. Studies of the ozone hole have benefited from IPY research as well, with new connections identified between the ozone concentrations above Antarctica and wind and storm conditions over the Southern Ocean. This information will improve predictions of climate and ozone depletion.

Many Arctic residents, including indigenous communities, participated in IPY's projects. Over 30 of these projects addressed Arctic social and human science issues, including food security, pollution, and other h
'/>"/>

Contact: Rhian Salmon
ipy.ras@gmail.com
44-771-537-1759
International Council for Science
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
2. Half time in the International Polar Year 2007-2008
3. Arctic climate models playing key role in polar bear decision
4. NASA expert to address Earths vanishing polar ice, April 10, at UD
5. Vanishing polar ice talk to be Webcast live, April 10
6. Federal polar bear research critically flawed, says study in INFORMS journal
7. Rare Antarctic fossils reveal extinction of tundra before full polar climate arrived
8. Dartmouth awarded NSF grant for new polar sciences, engineering grad program
9. Largest study of its kind implicates gene abnormalities in bipolar disorder
10. RV Polarstern on its way to East Siberian Sea
11. Experts meet on need for new rules to govern worlds fragile polar regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a leader ... million in Series A1 funding led by UK-based Eurovestech. ... participated in the investment round. "We are ... community adopts next-generation sequencing and seeks new approaches for ... Reid Robison , MD MBA, and CEO of Tute ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... researchers, the rapid pace of climate change is threatening the future ... that one species of fish could not even survive in water ... says the lead author of the study, Dr Jodie Rummer from ... at James Cook University. Dr Rummer and her colleagues studied ...
... Columbia -- Yoho National Park,s 505-million-year-old Burgess Shale ... a very primitive human relative is one of ... a century after its discovery, a compelling sequel has ... a new Burgess Shale fossil site has been located ...
... breast cancer, also kills a fungus that causes a deadly ... lead to new treatments for a disease that kills more ... online open-access journal of the American Society for Microbiology (ASM.) ... to see if tamoxifen can be used as a drug ...
Cached Biology News:Fish living near the equator will not thrive in the warmer oceans of the future 2Researchers discover 'epic' new Burgess Shale site in Canada's Kootenay National Park 2Breast cancer drug fights fungal disease 2
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced the results ... "This was a transformational year in Relmada,s ... future for our company," said Sergio Traversa , ... we have executed on key financial, human resource and ...
(Date:12/17/2014)... 17, 2014 Based on the ... surgical imaging market is dominated by four major ... imaging market. These players include GE Healthcare (U.K.), ... (Germany). , Full Report Copy at ... Healthcare can be attributed to its strong product ...
(Date:12/17/2014)... Achim Noack has been named global vice ... this position, Noack will assist Jerry Stoller, CEO and ... strategy and supervise global marketing management and implementation of ... knowledge and experience in the crop protection industry,” says ... innovative thinking will be a great asset for Stoller ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Once ... to provide a larger packaged waste water treatment plant ... King Abdullah Economic City (KAEC). Two years ago Bioshaft ... Jeddah Gate Development, serving two residential towers with an ... is over a quarter million gallons per day and ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... Trial in Medullary Thyroid Cancer Planned to Initiate ... 16 ,Exelixis, Inc. (Nasdaq: EXEL ) announced ... Drug Administration (FDA) have reached agreement on the ... anticancer compound targeting,MET, RET, and VEGFR2, via the ...
... Thermage Inc. To, Drive Coapt,s Growth In ... June 13 Coapt Systems, Inc.,developer of bioabsorbable implants ... and sports medicine markets, announced today the,appointment of Laureen ... as a member of the company,s Board of Directors. ...
... landmark IRIS trial, which established Gleevec as standard ... of care, - Study did not ... molecular responses with 800 vs. 400 ... optimize treatment benefit for individual ...
Cached Biology Technology:Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 2Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 3Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 4Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 5Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 2Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 3Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 2Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 3Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 4Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 6Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 7Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 8Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 9Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 10Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 11Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 12Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 13
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
... Cryo/CryoPlus Inventory Racks for ... available with cardboard or stainless ... or 5ml cryo vials. ... racks available. Platform risers ...
... This volume provides excellent background information, detailed ... of major HIV proteins including: the HIV ... and protease. Expression of HIV proteins using ... assays; HIV/CD4 interactions; transient assays for Nef-induced ...
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Biology Products: